These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27423380)

  • 21. Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus.
    Braga A; Uberti EM; Fajardo Mdo C; Viggiano M; Sun SY; Grillo BM; Padilha SL; de Andrade JM; de Souza CB; Madi JM; Maestá I; Silveira E
    J Reprod Med; 2014; 59(5-6):241-7. PubMed ID: 24937964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.
    Sun SY; Melamed A; Joseph NT; Gockley AA; Goldstein DP; Bernstein MR; Horowitz NS; Berkowitz RS
    Int J Gynecol Cancer; 2016 Feb; 26(2):367-70. PubMed ID: 26588240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic study on gestational trophoblastic diseases in Japan.
    Yamamoto E; Nishino K; Niimi K; Ino K
    J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.
    Joneborg U; Folkvaljon Y; Papadogiannakis N; Lambe M; Marions L
    Acta Oncol; 2018 Aug; 57(8):1094-1099. PubMed ID: 29451409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for gestational trophoblastic neoplasia development of singleton normal fetus with partial hydatidiform mole pregnancy: A retrospective cohort and literature review.
    Zhong L; Song L; Yin R; Li Q; Wang D
    J Obstet Gynaecol Res; 2023 Feb; 49(2):479-486. PubMed ID: 36328803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational study.
    Campos V; Paiva G; Padron L; Freitas F; Pedrotti LG; Sun SY; Viggiano M; Oliveira L; Rohr L; Madi JM; Arrym TP; Oliveira P; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Braga A; Berkowitz RS
    BJOG; 2023 Feb; 130(3):292-302. PubMed ID: 36209485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Features of Gestational Trophoblastic Disease in Aged Women in South Vietnam.
    Nguyen BQ; Vo TM; Phan VTT; Nguyen C; Vu H; Vo B
    Yonsei Med J; 2023 Apr; 64(4):284-290. PubMed ID: 36996900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of postmolar gestational trophoblastic neoplasia by early diagnosis and treatment.
    Ben-Arie A; Deutsch H; Volach V; Peer G; Husar M; Lavie O; Gemer O
    J Reprod Med; 2009 Mar; 54(3):151-4. PubMed ID: 19370899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women.
    Braga A; Moraes V; Maestá I; Amim Júnior J; Rezende-Filho Jd; Elias K; Berkowitz R
    Int J Gynecol Cancer; 2016 Jun; 26(5):984-90. PubMed ID: 26905335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience.
    Moodley M; Tunkyi K; Moodley J
    Int J Gynecol Cancer; 2003; 13(2):234-9. PubMed ID: 12657130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia.
    St Laurent JD; Lin LH; Owen DM; Maestá I; Castaneda A; Hasselblatt KT; Goldstein DP; Horowitz NS; Berkowitz RS; Elias KM
    Reprod Sci; 2021 Nov; 28(11):3200-3211. PubMed ID: 34129219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
    de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
    Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
    Gadducci A; Lanfredini N; Cosio S
    Gynecol Endocrinol; 2015; 31(9):673-8. PubMed ID: 26288335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current clinical features of complete and partial hydatidiform mole in Sweden.
    Joneborg U; Marions L
    J Reprod Med; 2014; 59(1-2):51-5. PubMed ID: 24597287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases.
    Massardier J; Golfier F; Journet D; Frappart L; Zalaquett M; Schott AM; Lenoir VT; Dupuis O; Hajri T; Raudrant D
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):84-7. PubMed ID: 19193484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.